新股发行改革勿再挑战市场底线(IPO reform no longer challenge the bottom line of the market).docVIP

  • 5
  • 0
  • 约 7页
  • 2017-10-07 发布于河南
  • 举报

新股发行改革勿再挑战市场底线(IPO reform no longer challenge the bottom line of the market).doc

新股发行改革勿再挑战市场底线(IPO reform no longer challenge the bottom line of the market)

新股发行改革勿再挑战市场底线(IPO reform no longer challenge the bottom line of the market) IPO reform no longer challenge the bottom line of the market On the one hand, the market plays a decisive role, while the government plays a better role.. This sentence is used to describe the reform of Chinas new shares IPO more appropriate. At the beginning of 2014, IPO was the first to return to investors eyes after more than a year of new shares. From IPO restart to Monday, the 14 trading days, A shares market capitalization of more than trillion, new shares blowout issue at the same time, the Shanghai Composite Index has continued to hit a new low, Monday, Shanghai Stock Exchange returned to the 1 era. In November last year, the Commission launched China to market-oriented IPO reform measures, but from the actual effect after the launch, not only the old problems have not been fully alleviated, even worsening trend, Chinese IPO new problems following the heel. Thus appeared the government administration hand forced to reappear the rivers and lakes awkward move. Jiangsu aosaikang pharmaceutical industry in the online purchase on the eve of the Commission to suspend the issue; the Chinese said that the IPO market is not let things drift on the evening of third, and the introduction of new regulations to strengthen the supervision of the IPO. After the introduction of new regulations, Huijin shares netposa, NSFocus, Henghua technology and Ciming examination, five companies have issued to suspend the issuance of new shares or delayed publishing notice; crystal science and technology day subscription Commission launched an emergency stop; Chinese IPO process checks, involving 13 underwriters and 44 institutions; Shaanxi coal IPO financing scale halved; listed Neway shares on the first day was a temporary suspension; Wang Liang shares suspended IPO issue; the media questioned i-biological issued under the net insider. The IPO restart crashed out of the IPO reform tells us that even if the di

文档评论(0)

1亿VIP精品文档

相关文档